Citation: | YAO Chengzhi, XU Jieru, ZHANG Min, DUAN Zhaohui, ZHAO Xiangling, XIONG Wenjing, RANG Weiqing. Analysis of trends in thyroid cancer deaths in China from 1990 to 2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(6): 726-732. doi: 10.16462/j.cnki.zhjbkz.2023.06.019 |
[1] |
沈婉莹, 谢靖, 周维, 等. 2005—2015年中国甲状腺癌死亡趋势分析[J]. 实用预防医学, 2021, 28(6): 641-644. DOI: 10.3969/j.issn.1006-3110.2021.06.001.
Shen WY, Xie J, Zhou W, et al. Trend of deaths from thyroid cancer in China, 2005-2015 [J]. Pract Prev Med, 2021, 28(6): 641-644. DOI: 10.3969/j.issn.1006-3110.2021.06.001.
|
[2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
[3] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
|
[4] |
赫捷, 魏文强. 2019中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2021: 198-199.
He J, Wei WQ. 2019 China cancer registry annual report[M]. Bejing: People′s Medical Publishing House, 2021: 198-199.
|
[5] |
赫捷. 2018中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2019: 178-179.
He J. 2018 China cancer registry annual report[M]. Bejing: People′s Medical Publishing House, 2019: 178-179.
|
[6] |
IHME.The Global Burden of Disease: a critical resource for informed policymaking [EB/OL]. (2014-04-18) [2022-06-03].
|
[7] |
李慧贤, 胡丽, 郑焱, 等. 基于全球疾病负担(GBD)大数据的中国银屑病流行病学负担分析[J]. 中国皮肤性病学杂志, 2021, 35(4): 386-392. DOI: 10.13735/j.cjdv.1001-7089.202003197.
Li HX, Hu L, Zheng Y, et al. Analysis of the epidemiological burden of psoriasis in China based on the big data of global burden of disease study(GBD) [J]. Chin J Dermatovenereol, 2021, 35(4): 386-392. DOI: 10.13735/j.cjdv.1001-7089.202003197.
|
[8] |
屈彦, 王天一, 杨津, 等. GBD数据库的数据提取方法与流程[J]. 中国循证心血管医学杂志, 2019, 11(9): 1043-1046. DOI: 10.3969/j.issn.1674-4055.2019.09.04.
Qu Y, Wang TY, Yang J, et al. GBD database application and data extraction methods and processes [J]. Chin J Evid Based Cardiovasc Med, 2019, 11(9): 1043-1046. DOI: 10.3969/j.issn.1674-4055.2019.09.04.
|
[9] |
王鹏举, 余莉, 王一卉, 等. 2004―2017年全国0~10岁人群乙型肝炎发病趋势[J]. 中华疾病控制杂志, 2021, 25(5): 571-576. DOI: 10.16462/j.cnki.zhjbkz.2021.05.014.
Wang PJ, Yu L, Wang YH, et al. Incidence trend of hepatitis B among people aged 0-10 years in China from 2004 to 2017 [J]. Chin J Dis Control Prev, 2021, 25(5): 571-576. DOI: 10.16462/j.cnki.zhjbkz.2021.05.014.
|
[10] |
Rosenberg PS. A new age-period-cohort model for cancer surveillance research [J]. Stat Methods Med Res, 2019, 28(10-11): 3363-3391. DOI: 10.1177/0962280218801121.
|
[11] |
中华耳鼻咽喉头颈外科杂志编辑委员会头颈外科学组. 分化型甲状腺癌诊治指南专题讨论[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(11): 881-886. DOI: 10.3760/cma.j.issn.1673-0860.2011.11.001.
Head and neck surgery group, Editorial Committee of Chinese Journal of Otolaryngology Head and neck surgery. Special discussion on diagnosis and treatment guidelines of differentiated thyroid cancer [J]. Chin J Otorhinolaryngol Head Neck Surg, 2011, 46(11): 881-886. DOI: 10.3760/cma.j.issn.1673-0860.2011.11.001.
|
[12] |
陈磊, 徐杰茹, 王冕, 等. 1990―2019年中国肾癌死亡趋势及其年龄-时期-队列分析[J]. 中华疾病控制杂志, 2021, 25(9): 1026-1033, 1111. DOI: 10.16462/j.cnki.zhjbkz.2021.09.007.
Chen L, Xu JR, Wang M, et al. Analysis for mortality trend and age-period-cohort of kidney cancer in China from 1990 to 2019 [J]. Chin J Dis Control Prev, 2021, 25(9): 1026-1033, 1111. DOI: 10.16462/j.cnki.zhjbkz.2021.09.007.
|
[13] |
吴春晓, 顾凯, 庞怡, 等. 2016年上海市甲状腺癌发病和死亡情况与2002—2016年间变化趋势分析[J]. 外科理论与实践, 2022, 27(1): 58-65. DOI: 10.16139/j.1007-9610.2022.01.014.
Wu CX, Gu K, Pang Y, et al. Thyroid cancer incidence and mortality in Shanghai China 2016 and trends from 2002 to 2016 [J]. J Surg Concepts Pract, 2022, 27(1): 58-65. DOI: 10.16139/j.1007-9610.2022.01.014.
|
[14] |
Haymart MR. Understanding the relationship between age and thyroid cancer [J]. Oncologist, 2009, 14(3): 216-221. DOI: 10.1634/theoncologist.2008-0194.
|
[15] |
Nilubol N, Zhang LS, Kebebew E. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin [J]. Thyroid, 2013, 23(6): 695-702. DOI: 10.1089/thy.2012.0269.
|
[16] |
宋炳豹, 姜瑛, 姜福全, 等. 老年男性甲状腺癌临床分析[J]. 现代仪器与医疗, 2013, 19(5): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYI201305015.htm
Song BB, Jiang Y, Jiang FQ, et al. Clinical analysis of elderly male thyroid cancer [J]. Mod Instrum Med Treat, 2013, 19(5): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYI201305015.htm
|
[17] |
晏月平, 黄美璇, 郑伊然. 中国人口年龄结构变迁及趋势研究[J]. 东岳论丛, 2021, 42(1): 148-163. DOI: 10.15981/j.cnki.dongyueluncong.2021.01.015.
Yan YP, Huang MX, Zheng YR. Study on the changes and trends of population age structure in China [J]. Dongyue Tribune, 2021, 42(1): 148-163. DOI: 10.15981/j.cnki.dongyueluncong.2021.01.015.
|
[18] |
Kim HJ, Kim NK, Choi JH, et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer [J]. Clin Endocrinol (Oxf), 2013, 78(1): 134-140. DOI: 10.1111/j.1365-2265.2012.04506.x.
|
[19] |
吴长华, 王亮, 陈万军. 肥胖与甲状腺癌[J]. 肿瘤, 2016, 36(7): 829-834. DOI: 10.3781/j.issn.1000-7431.2016.55.189.
Wu CH, Wang L, Chen WJ. Relationship between obesity and thyroid carcinoma [J]. Tumor, 2016, 36(7): 829-834. DOI: 10.3781/j.issn.1000-7431.2016.55.189.
|
[20] |
平卫伟, 谭红专, 曹文君, 等. 成年人生活方式与体质指数的相关性研究[J]. 中华疾病控制杂志, 2016, 20(11): 1184-1186. DOI: 10.16462/j.cnki.zhjbkz.2016.11.027.
Ping WW, Tan HZ, Cao WJ, et al. Correlation study between lifestyle and BMI in adults [J]. Chin J Dis Control Prev, 2016, 20(11): 1184-1186. DOI: 10.16462/j.cnki.zhjbkz.2016.11.027.
|
[21] |
Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables [J]. Clin Oncol (R Coll Radiol), 2010, 22(6): 395-404. DOI: 10.1016/j.clon.2010.05.004.
|
[22] |
陆一丹, 时开元, 欧笛, 等. 甲状腺微小癌预后风险评估与治疗决策的研究进展[J]. 中国肿瘤, 2020, 29(12): 962-969. DOI: 10.11735/j.issn.1004-0242.2020.12.A013.
Lu YD, Shi KY, Ou D, et al. Progress on prognostic risk assessment and treatment strategy for thyroid microcarcinoma [J]. China Cancer, 2020, 29(12): 962-969. DOI: 10.11735/j.issn.1004-0242.2020.12.A013.
|
[23] |
Li Y, Piao J, Li M. Secular trends in the epidemiologic patterns of thyroid cancer in China over three decades: an updated systematic analysis of global burden of disease study 2019 data [J]. Front Endocrinol (Lausanne), 2021, 12: 707233. DOI: 10.3389/fendo.2021.707233.
|
[24] |
《中国肿瘤临床》编辑部. 4·15全国肿瘤防治宣传周[J]. 中国肿瘤临床, 2014, 41(9): 570. https://xuewen.cnki.net/CCND-ZSRB202304190080.html
Clinical Oncology in China. April 15 national Cancer Prevention and Treatment Publicity Week [J]. Chin J Clin Oncol, 2014, 41(9): 570. https://xuewen.cnki.net/CCND-ZSRB202304190080.html
|
[25] |
Shao YH, Tsai K, Kim S, et al. Exposure to tomographic scans and cancer risks [J]. JNCI Cancer Spectr, 2019, 4(1): pkz072. DOI: 10.1093/jncics/pkz072.
|
[26] |
欧阳鑫, 谢婉莹, 秦春宏. 甲状腺癌的流行病学特征及其危险因素[J]. 实用医药杂志, 2015, 32(4): 312-315. DOI: 10.14172/j.cnki.issn1671-4008.2015.04.009.
Ouyang X, Xie WY, Qin CH. Epidemic characteristics of thyroid cancer, and its risk factors [J]. Pract J Med Pharm, 2015, 32(4): 312-315. DOI: 10.14172/j.cnki.issn1671-4008.2015.04.009.
|
[27] |
世界卫生组织. "过度诊断"可致甲状腺癌误诊率高[J]. 上海医药, 2016, 37(17): 77. https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY201617023.htm
World Health Organization. "Overdiagnosis" can lead to a high misdiagnosis rate of thyroid cancer, according to the World Health Organization [J]. Shanghai Med Pharm J, 2016, 37(17): 77. https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY201617023.htm
|